Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection.
BACKGROUND
The presence of fibronectin fragments has been observed in some inflammatory diseases and is believed to reflect tissue breakdown. In this study, possible fibronectin fragmentation and alterations in its domain and sialyl and fucosyl glycotope expressions were analyzed in amniotic fluids in relation to intrauterine infection.


METHODS
Samples of amniotic fluid were taken from normal pregnancies and pregnancies (28 and 42 weeks) complicated by intrauterine infection. Fibronectin fragmentation was analyzed by immunoblotting. The expression of cellular, fibrin, C-terminal and EDA fibronectin domains, as well as alpha2,3- and alpha2,6-linked sialic acids, and alpha1,6-, alpha1,3- and alpha1,2-linked fucoses, was determined by ELISA, using domain-specific monoclonal antibodies and specific lectins, respectively.


RESULTS
Amniotic fibronectin immunoblots from pregnancies with intrauterine infection revealed three groups of results. In group 1, with the native fibronectin band, and in group 2 with bands of native fibronectin and several fibronectin fragments, only higher alpha1,6-linked fucose expression was observed. In the infection group 3, characterized by profound fragmentation of fibronectin, lower expression of all fibronectin domains analyzed and of alpha1,6-linked sialic acid and alpha1,2-linked fucose was found.


CONCLUSIONS
Amniotic fibronectin status was found to be associated with pregnancy complicated by intrauterine infection. Such alterations could have a potential diagnostic value in the prevention of or intervention in fetal intrauterine infection.
Hirnle
Lidia
L
Department and Clinic of Reproduction and Obstetrics, Wrocław Medical University, Wrocław, Poland.
Katnik-Prastowska
Iwona
I
D000328:Adult; D000653:Amniotic Fluid / Q000737:chemistry; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005353:Fibronectins / Q000032:analysis* / Q000737:chemistry; D006801:Humans; D015151:Immunoblotting; D007239:Infections / Q000175:diagnosis; D010446:Peptide Fragments / Q000032:analysis* / Q000737:chemistry; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000517:prevention & control
D005353:Fibronectins; D010446:Peptide Fragments